Argos Technologies, Inc

American Regent, Inc, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. We have locations in New York, Ohio, and Pennsylvania and sales territories nationwide.

American Regent continues to position its business for sustainable growth, with significant investments in the modernization and expansion of our U.S. manufacturing sites. These enhancements are expected to strengthen our business and represents our commitment to the ongoing success of our company and its employees.

Supporting patient health is our guiding principle and our promise is to provide the healthcare marketplace with a steady supply and broad portfolio of brand and generic specialty injectables.

Own products (APIs) for the generic pharmaceutical industry.

We provide quality products and services, consistently,
reliably responsibly and continuously applying some of the world’s
most difficult to handle chemical technologies.
Our independent one-site,
single entity corporate setup enables


Synthesis: Manufacturing services and products for all user industries,
using Archimica´s highly differentiated setup and technologies
APIs, Building blocks, GMP intermediates, Regulatory Starting Materials
For all global markets including the United States of America,
in total Archimica products reach 25 countries.

We are Viatris. A new kind of global healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®.

Formed in November 2020, we bring together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. At Viatris, our portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines and a growing portfolio of biosimilars. With a global workforce of more than 40,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.

Learn more about Viatris at https://www.viatris.com/en and https://investor.viatris.com, and connect with us on Twitter at https://www.twitter.com/viatrisinc and YouTube at https://www.youtube.com/c/viatris

We encourage you to comment, ask questions and engage in conversation. By interacting with us on social media, you agree to abide by our community guidelines: https://news.viatris.com/social-media-guidelines

Viatris and its recruiting firms do not request banking or credit card information in connection with Viatris recruiting activities. Additionally, Viatris representatives do not request payment or personal bank information as part of our recruitment process. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

In 1933 Byrne began selling high quality milk in glass bottles and delivering it to Central New York homes in horse-drawn wagons. It was the commitment to exceptional quality and the strong desire to produce the finest products every day to its customers that set Byrne apart.

Today, Byrne is a fourth generation, family-owned producer and distributor of Greek Yoghurt, Conventional Yogurt, Sour Cream, Milk, Cream, Ice Cream and a variety of other dairy products. Based in Central New York, with its abundant supply of high quality milk, Byrne works with over 250 local family farms. Byrne's average farm is only 35 miles from it’s plants where they receive around 50 million pounds of milk each month. Strong relationships with their farmers has been a cornerstone of Byrne's business lasting through generations and bonded by handshakes not contracts.

Byrne currently has three manufacturing facilities including a Ice Cream Plant located in Syracuse, N.Y, an Ultra High Temperature (UHT) Pasteurization Plant in DeWitt, N.Y., and a Cultured Plant located in Cortlandville, N.Y.

Byrne has additional plans for their new Cultured Plant and overall 133 acre site in Cortlandville, N.Y. Future plans include an artisanal cheese making operation, tourist facility to allow the public to view the manufacturing process, and an outdoor amphitheater for concerts and other gatherings.

Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market.

With over 40 years’ experience and a growing team of over 2,100 experts servicing global clients from sites in North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.

Cambrex offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs. In addition, Cambrex can support conventional dosage forms including oral solids, semi-solids and liquids and has the expertise to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.